The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Diflucan 10 mg/ml powder for oral suspension

Pfizer Healthcare IrelandPA0822/211/006

Main Information

Trade NameDiflucan 10 mg/ml powder for oral suspension
Active SubstancesFluconazole
Dosage FormPowder for oral suspension
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/211/006

Group Information

ATC CodeJ02AC Triazole derivatives
J02AC01 fluconazole


License statusAuthorised
Licence Issued12/11/1991
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back